… current malaria vaccine reaches the levels of durable efficacy likely to be required for vaccine
… -liver-stage vaccines in combination produces much greater efficacy and this combination …

… to malaria vaccine development. We aimed to develop a genetically attenuated blood-stage
vaccine and test its safety, … -stage GAP malaria vaccine and characterize its safety, infectivity, …

… not contain clinical data for administration of a malaria-vaccine candidate in a confirmed HIV-…
report safety and immunogenicity results of a malaria vaccine in an HIV-infected population. …

… malaria occurs in young children [5]. In order to ultimately evaluate the safety and efficacy of
the RTS,S/AS02A candidate vaccine … escalation and dose escalation safety trials in children. …

… Efficacy of RTS,S/AS02 malaria vaccine against Plasmodium falciparum infection in semi-…
Safety of the RTS,S/AS02D candidate malaria vaccine in infants living in a highly endemic …

… for other diseases are being evaluated first in malaria. We describe progress in malaria
vaccine development in the past 5 years: reasons for cautious optimism, the type of vaccine that …

… malaria when used along with other measures [3]. A minimally 50% efficacious malaria
vaccine that lasts at least a year is critical to the 2015 landmark goals of the Malaria Vaccine …

… Malaria Vaccine Symposium. In this meeting report, we highlight the progress on different
malaria vaccine … and genetic findings that may impact malaria vaccine responses and efficacy. …

… The RTS,S malaria vaccine formulations we studied were designed to induce strong
immune responses to the P. falciparum CS antigen. Our data indicate that antibody and cellular …

… In this Perspective, we examine the background and rationale for different malaria vaccine
… of several of the most prominent malaria vaccines in or nearing clinical trials since the year …